Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT05249894
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of non M3 Acute Myeloid Leukemia according to WHO (World Health Organization) 2008 criteria
* Age \>= 18 years and \<= 70 years
* Patient had received intensive chemotherapy either as induction or consolidation regimen
* Period of observation: January 2001 - December 2019
* Written informed consent
Exclusion Criteria:
* Diagnosis of Acute Promyelocytic Leukemia (M3 AML)
* Age \< 18 or \>70 years
* Patient had not received intensive chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05249894
Study Brief:
Protocol Section:
NCT05249894